As with any new category of medicine, change will not happen overnight. There is further work to be done to adapt clinical practice guidelines, payer coverage policies and prescriber behavior to embrace digital therapeutics at scale - but we continue to believe a data-driven approach combined with thoughtful planning will get us there.
Austin Speier, Chief Strategy Officer